What is Eagle Genomics?
Eagle Genomics is at the forefront of innovation, merging biology, data sciences, and bioinformatics to accelerate the generative economy. Its proprietary AI-augmented knowledge discovery platform, e[datascientist], is designed to drastically reduce the time scientists spend analyzing multi-dimensional data, enabling faster development of next-generation products. The platform supports the entire innovation workflow, from hypothesis generation to product claims, across key industries including Food and Nutrition, Beauty and Personal Care, AgBio, and BioPharma. Eagle Genomics is actively forging strategic alliances with leading scientific institutions, particularly those focused on the microbiome, and has contributed to shaping the UK's Microbiome Strategic Roadmap.
How much funding has Eagle Genomics raised?
Eagle Genomics has raised a total of $16.3M across 6 funding rounds:
Unspecified
$918K
Unspecified
$661K
Unspecified
$1.3M
Unspecified
$1M
Unspecified
$3.5M
Unspecified
$9M
Unspecified (2013): $918K with participation from Cambridge Capital Group, London Business Angels, and Midven
Unspecified (2013): $661K led by London Business Angels and Angel CoFund
Unspecified (2016): $1.3M supported by Newable Private Investing and Angels in MedCity
Unspecified (2018): $1M featuring UK Innovation & Science Seed Fund
Unspecified (2019): $3.5M backed by Newable Private Investing, Environmental Technologies Fund, and UK Innovation & Science Seed Fund
Unspecified (2020): $9M with participation from ETF Partners LLP
Key Investors in Eagle Genomics
ETF Partners LLP
ETF Partners is a venture capital firm that invests in technology companies driving sustainability through innovation. They provide capital and expertise to support talented entrepreneurs and management teams, with a focus on making a tangible difference.
Cambridge Capital Group
Cambridge Capital Group is a seasoned business angel network with a 25-year history of investing in UK technology startups. They focus on early-stage opportunities across sectors like medtech and AI, aiming to support high-tech entrepreneurs and deliver strong investor returns.
London Business Angels
London Business Angels is a prominent network that connects early-stage companies with experienced investors. They play a crucial role in the UK's startup ecosystem, facilitating investment and providing strategic support to high-growth potential businesses.
What's next for Eagle Genomics?
The substantial enterprise-level funding positions Eagle Genomics for accelerated growth and expanded market penetration. This strategic investment is expected to fuel further development of its AI-augmented platform, enhance its scientific partnerships, and broaden its reach into critical sectors like BioPharma and AgBio. The company's focus on enabling science-led innovation for safer and more sustainable products aligns with global trends, suggesting a strong trajectory for future expansion and impact.
See full Eagle Genomics company page
